The nonpartisan voting reform group FairVote released a new report Monday that shows that 70 major party statewide and ...

The statement from the Holy See press office described Francis as having a “flu-like state.” Through much of last autumn and ...

The move was described as a “precaution” in the statement from the Vatican days before he is to embark on a trip to Belgium ...

The Vatican confirmed that plans remain in place for Pope Francis to travel despite having canceled all his audiences Monday ...

The FDA granted fast track designation to EO-3021 for the treatment of advanced or metastatic gastric and gastroesophageal ...

A short course of treatment with RNS60, as an add-on to riluzole, extended the survival of ALS patients by about six months, ...

LEXINGTON, Mass. and AMSTERDAM, Sept. 23, 2024 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing ...

The FDA has approved Tremfya® (guselkumab) for the treatment of adult patients with moderately to severely active ulcerative colitis (UC).

In addition to other MM indications, Isatuximab's anti-CD38 competitor on the US market, daratumumab (Darzalex — Johnson & Johnson), also carries a first-line indication for transplant-ineligible MM ...